Who invested in WhiteLab Genomics?
WhiteLab Genomics, a Biotech & Pharma startup from France, raised €23.2 million in a Series B round announced on 6 October 2026. Investors: AVP (lead), Blast Club, Omnes Capital, Debiopharm and 1 more named in the source.
WhiteLab Genomics
€23.2 millionSeries BBiotech & PharmaAVPleadBlast ClubOmnes CapitalDebiopharm · +1 more in the source
Franceeu-startups.com
Questions founders ask
- Who invested in WhiteLab Genomics?
- AVP, Blast Club, Omnes Capital and Debiopharm invested in WhiteLab Genomics's Series B round, announced on 6 October 2026 (source: eu-startups.com).
- Who led WhiteLab Genomics's Series B round?
- AVP, according to eu-startups.com.
- How much did WhiteLab Genomics raise?
- €23.2 million in its Series B round, as reported by eu-startups.com.
Raising next? See which investors fit your round.
In 30 minutes you'll know which funds matter for your round.
Request accessRounds are read from public funding coverage and matched against our investor database. Every line links to the article it came from — that article, not this page, is the source. Amounts are quoted exactly as the article stated them; we do not convert currencies. Individual angel investors named in an article are not listed here.
Something wrong? Tell us what to correct and we will fix it. To be removed from Oka entirely, use /remove-me.